Karolinska Development re-invests 300,000 € in Eribis in accordance to milestone achievements to bridge the company into further development stages.
You are here:
Karolinska Development re-invests 300,000 € in Eribis in accordance to milestone achievements to bridge the company into further development stages.
| Copyright © Eribis Pharmaceuticals. Developed by dreamforce.se. This web site uses cookies. Read more. |